Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Emi Shoji-Hosaka

Defucosylated Chimeric Anti-Cc Chemokine Receptor 4 IgG1 With Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma

Cancer Research

Oncology

2004

English

Related publications

CXC Chemokine Receptor 3 and CC Chemokine Receptor 4 Expression in T-Cell and NK-Cell Lymphomas With Special Reference to Clinicopathological Significance for Peripheral T-Cell Lymphoma, Unspecified

Clinical Cancer Research

Cancer Research

Oncology

2004

English

Producing Defucosylated Antibodies With Enhanced in Vitro Antibody-Dependent Cellular Cytotoxicity via FUT8 Knockout CHO-S Cells

Engineering in Life Sciences

Bioengineering

Environmental Engineering

Biotechnology

2017

English

Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma

Journal of Hematology and Oncology

English

Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas

Current Hematologic Malignancy Reports

English

CC Chemokine Receptor 7 Contributes to Gi-Dependent T Cell Motility in the Lymph Node

Journal of Immunology

Allergy

Immunology

2007

English

A Novel Anti‑EGFR Monoclonal Antibody (EMab‑17) Exerts Antitumor Activity Against Oral Squamous Cell Carcinomas via Antibody‑dependent Cellular Cytotoxicity and Complement‑dependent Cytotoxicity

English

NK Cell-Mediated Anti-Leukemia Cytotoxicity Is Enhanced Using a NKG2D Ligand MICA and Anti-Cd20 SCFV Chimeric Protein

European Journal of Immunology

Allergy

Immunology

2018

English

T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody

Journal of Immunology

Allergy

Immunology

2002

English

Chimeric Antigen Receptor Engineered Human Gamma Delta T Cells; Enhanced Cytotoxicity With Retention of Cross Presentation

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Emi Shoji-Hosaka

Defucosylated Chimeric Anti-Cc Chemokine Receptor 4 IgG1 With Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma

Related publications

CXC Chemokine Receptor 3 and CC Chemokine Receptor 4 Expression in T-Cell and NK-Cell Lymphomas With Special Reference to Clinicopathological Significance for Peripheral T-Cell Lymphoma, Unspecified

Producing Defucosylated Antibodies With Enhanced in Vitro Antibody-Dependent Cellular Cytotoxicity via FUT8 Knockout CHO-S Cells

Artesunate Shows Potent Anti-Tumor Activity in B-Cell Lymphoma

Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas

CC Chemokine Receptor 7 Contributes to Gi-Dependent T Cell Motility in the Lymph Node

A Novel Anti‑EGFR Monoclonal Antibody (EMab‑17) Exerts Antitumor Activity Against Oral Squamous Cell Carcinomas via Antibody‑dependent Cellular Cytotoxicity and Complement‑dependent Cytotoxicity

NK Cell-Mediated Anti-Leukemia Cytotoxicity Is Enhanced Using a NKG2D Ligand MICA and Anti-Cd20 SCFV Chimeric Protein

T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody

Chimeric Antigen Receptor Engineered Human Gamma Delta T Cells; Enhanced Cytotoxicity With Retention of Cross Presentation